EASD 2011 - Cardiology Conference Coverage

Heartwire

Lipid/Metabolic

No increased CVD events with DPP-4 inhibitors

Sep 19, 2011 16:30 EDT

UPDATED // Offering a rare glimmer of good cardiovascular-disease news for a diabetes drug, a new meta-analysis suggests that dipeptidyl peptidase-4 inhibitors, at worst, do not increase the risk of cardiovascular events and, at best, may even have a protective effect.

Medscape Medical News

Glucose disturbances appear years before diabetes diagnosis

2 COMMENTS - Sep 19, 2011 14:30 EDT

Patients who receive a diagnosis of type 2 diabetes can show elevations in blood levels of glucose and HbA_1c as much as 10 years earlier, with sharp rises in the few years prior to diagnosis.

Lipid/Metabolic

Registry data support "J-curve" CV risk theory for HbA_1cin diabetes

1 COMMENT - Sep 16, 2011 16:00 EDT

In an intriguing secondary analysis, investigators of a large, Swedish cohort study say that the J curve seen in patients with diabetes taking insulin or oral agents was most pronounced among those with the lowest education levels.

Medscape Medical News

Diet high in protein, processed meat raises risk of diabetes

Sep 16, 2011 10:00 EDT

A large population-based Swedish study suggests that substituting fiber-rich foods may be helpful in reducing the risk of type 2 diabetes.

Medscape Medical News

Twice-daily aspirin yields better platelet inhibition in diabetics

4 COMMENTS - Sep 15, 2011 16:15 EDT

For diabetic patients on aspirin for cardioprotection, twice-daily dosing is better than doubling once-daily doses in those patients who have rapid recovery of platelet COX-1 activity.

Lipid/Metabolic

Should you start a statin in a newly diagnosed diabetic?

39 COMMENTS - Sep 15, 2011 13:30 EDT

Mounting evidence supporting a link between statins and new-onset diabetes should give clinicians pause for thought when initiating drug therapy in people with prediabetes or even a new diabetes diagnosis, one expert argues.

Lipid/Metabolic

Postprandial, but not fasting, glucose predicts CV risk in type 2 diabetes

15 COMMENTS - Sep 15, 2011 10:15 EDT

Lead investigator of an analysis of long-term data from the San Luigi Gonzaga Diabetes Study says a blood test two hours after lunch is a strong predictor of major events and, at least for all-cause mortality, as predictive as HbA_1c.

Lipid/Metabolic

Cardiovascular safety of diabetes drugs: The way forward

6 COMMENTS - Sep 14, 2011 10:15 EDT

The long shadow cast by the rosiglitazone controversy, as well as newer cancer concerns with pioglitazone, exenatide, and sitagliptin, are prompting calls for a revised approach to "signal detection" as well as to the conduct and reporting of clinical trials.

Lipid/Metabolic

Diabetes experts debate CV risk prediction in type 2 diabetes

2 COMMENTS - Sep 14, 2011 09:15 EDT

Now more than 30 years old, the UKPDS, called the "mother of all studies" in type 2 diabetes, is getting a bit long in the tooth for predicting the onset of major complications and deaths. But newer efforts and updates may be working at cross-purposes.

Heart failure

Poor glucose control in type 2 diabetes predicts HF hospitalizations

Sep 13, 2011 14:15 EDT

New Swedish data show a strong association between increasing levels of HbA_1c and hospital admissions for heart failure.

Lipid/Metabolic

Diabetics now number 366 million

Sep 13, 2011 09:30 EDT

Topline figures released at the European Association for the Study of Diabetes annual meeting show that the number of people living with diabetes worldwide has reached a staggering 366 million.